Glen Wakeman supports entrepreneurs and start-up companies alike by implementing strategies for growth, new market entry, company downsizing, mergers and much more. His education background consists of an MBA from the University of Chicago and BS in Economics and Finance from the University of Scranton. To give credit to his expertise in business development, organization, and implementation of strategic business management, he has also earned a certification in Six Sigma Black Belt. Visit dailyforexreport.com to know more about Glen Wakeman.
Wakeman has many flight miles under him; he has lived in six countries and has worked in 32 countries during a twenty-year career span with the financial service company GE Capital. During his time working at the organization, he fulfilled multi-faceted leadership positions in general management among various other business-related positions while working in the U.S. and internationally.
His last role and responsibility was CEO of GE Money Latin America. There, he built a startup which accrued over twelve billion dollars in assets and a hundred million dollars in yearly revenue. He established new partnerships, developed new products and constructed a network of over a thousand branches. In his previous role as a General Director of GE capital working in London, UK, he implemented strategies for a collection of organizations. With his assistance, the business revenue of the corporations grew from two million to ten million dollars in addition to adding over three billion dollars in assets.
Glen Wakeman uses his passion for enhancing business and individual accomplishments and strategies that are used to assess the five levels of an organization’s overall performance. These levels are leadership, human capital, execution, risk management, and governance.
Glen Wakeman is also the Founder and CEO of LaunchPad Holdings. This automated software is designed to enable entrepreneurs who are in the early stages of growing their business to organize their ideas into a plan of action. The software has a national targeting audience and is currently expanding in growth. The LaunchPad toolkit comes equipped with a comprehensive collection of tips for entrepreneurs that act as a guide to support them on their new career journey.
His dedication to helping organizations improve their current position and outlook has set the stage for him receiving awards for leadership, dedication, and corporate social responsibility. Read more about his interview at Ideamensch.
Oncotarget is a peer-reviewed journal that is distributed around the globe. Oncotarget focuses on examining the pathological effects that both cancer and cancer treatment has on the patient. In general, they look at the impact that cancer management programs have on the patient’s perspective of life and their overall satisfaction. Oncotarget is dedicated to discussing the newest treatment options that increase hope for the patient undergoing care for their cancer. Visit Soundcloud to listen an audio podcast of Oncotarget.
Recently, Oncotarget was able to report on some hopeful findings concerning treatment for papillary thyroid carcinoma. The cancer papillary thyroid carcinoma is widely known as one of the most disheartening cancers one can develop. This is due to its reputation of resisting the most common drug used in treating the cancer, vemurafenib. The reason the cancer becomes resistant to vemurafenib is that vemurafenib seeks to repair the mutated BRAF gene that causes papillary thyroid carcinoma. The body then develops in immunity to the drug so that in no longer works.
Many patients suffering from papillary thyroid carcinoma have had their cancer go into remission only to find out that it has returned incurable due to its drug resistance.
Know more: https://www.researchgate.net/journal/1949-2553_Oncotarget
Dr. Carmelo Nucero recently interviewed with Oncotarget to report why papillary thyroid carcinoma may now be treated with vemurafenib and another drug called palbociclib.
Dr. Carmelo Nucero was seeking to find a way to stop the body from attacking vemurafenib. After years of research and thousands of dollars, he was able to find for the first time a combination between vemurafenib and palbociclib which allowed for therapeutic strategy to treat papillary thyroid carcinoma.
The drug palbociclib is already FDA approved and has been used in breast cancer patients for years. When vemurafenib is mixed with palbociclib, the body will spend all of its time attacking palbociclib which will allow vemurafenib to continue healing the BRAF gene.
Dr. Carmelo Nucero is hopeful that since both drugs have Artie been approved by the FDA that they will soon greenlight the ability for oncologists to use this combination to treat papillary thyroid carcinoma. Download output styles at Endnote.com
To stay up-to-date subscribe to Oncotarget’s podcast now on iTunes.
Jorge Moll is fascinated with the correlation between morality and Science. He always wondered how the two are related, which is why he decided to experiment in 2006 along with a colleague named Jordan Grafman. Together, they invited several volunteers who would be observed, and as the study progresses, the two neuroscientists would be looking inside a brain scanner and see how the brain reacts to two different thoughts. The first idea would be about generosity and giving, while the second one would be about selfishness and being self-centered. The volunteers started closing their eyes and imagined what Jorge Moll wanted them to think. As the volunteers close their eyes and thoughts began to appear inside their mind, the two neuroscientists were surprised in what they have seen in the brain scanner’s monitor. Learn more about Jorge Moll at Google Scholar.
Jorge Moll noticed that the brain’s activity increases everytime the volunteers think about generosity. The monitor produces several graphs and movements on the mind, making them conclude that human brain tends to be more active when they give something. On the other hand, when they examined those who have thought about selfishness, nothing happens. This made Jorge Moll conclude that the brain is designed to be more active when giving, and do nothing when the person decides to be selfish. Another milestone of the study conducted by Jorge Moll is the discovery that there is a small area of the brain which comes out when an individual is engaged in a free activity. Read more about Jorge Moll at crunchbase.com.
The two neuroscientists have observed the small area inside the brain, and it only appears after an act of generosity has been performed. They have seen through the brain scanner that this small area inside the brain is responsible for sending hormones and other chemicals from the brain to the other parts of the body, explaining the pleasure that one feels when they decide to become generous. According to the volunteers, they felt something warm and light, and Jorge Moll told that this is because of the “helper’s high,” a phenomenon which is tied closely to those who are giving religiously and those who are not selfish.
Highland Capital has been providing advisory service to clients for many years and is well known for delivering on their promise. The company caters to clients from all walks of life and comes highly recommended.
Learning how to invest or choosing a good investment advisory firm is one of the most important things you can do for your financial future. There are many companies out there to choose from but you need a reliable firm on your side. Read more about Highland Capital at prnewswire.com.
In advising or guiding clients to select a suitable investment portfolio, the advisors at Highland Capital take into account factors such as economic trends, the client’s financial expectations and regulatory changes.
Advisors at Highland Capital also strive to build trust with clients. These professionals make it a top priority to answer their clients’ questions and address their concerns in a timely manner. They make their clients feel comfortable in discussing their financial issues with them.
Financial advisors and investment professionals at Highland Capital will assess your investment and money management needs and help you with selecting a viable investment opportunity. When you consult with the advisory team at Highland Capital you will be able to make the best decision for your situation, and also get the guidance you need to to plan for long-term goals. Visit highlandcap.com to know more.
Highland Capital has some of the most experienced and knowledgeable investment and wealth advisory professionals and can provide the resources and tools you need to reach your goal and enjoy great success. If you are serious about getting quality advice or guidance on how to invest wisely and achieve success, let the experts at Highland Capital help you.
When it comes to your financial or investment decisions, it is imperative to enlist the services of qualified professionals. If you want to ensure the best possible outcome in your investment, contact Highland Capital for top notch service. This company will help you with your investment or financial planning issues and ensure you reach your goal.
Highland Capital is a top rated advisory firm and you can contact them to find out more about the vast range of financial services they offer.
Can Organo Gold’s coffee blend be the best invention for health and wellness? Besides the beneficial effects of coffee or caffeine on Asthma, the cardiovascular system, and the digestive system, Organo Gold’s complementary ingredient, Ganoderma Lucidum, also is beneficial.
Ganoderma Lucidum, better known as Reishi, is a fungus grown in Eastern Asia. It’s been categorized as a Chinese medicinal herb, and thought of in Asia as the “mushroom of immortality.” Its properties bolster the immune system, and its relationship with the body’s anti-inflammatory processes. Follow Organo Gold on Facebook.
- This mushroom is said to helps reduce the exorbinant secretion of histamine, thus improving asthma
- Minerals (Iron, Zinc, Manganese, Magnesium, Potassium, Germanium, Calcium)
- B Vitamins, particularly B9
- Found to be useful for immunological diseases, and infections
Coffee is already known to be an effective bronchodilator, and how it can alleviate some asthma symptoms. In fact, clinical studies have shown that even low caffeine doses could improve lung activity for up to four hours. The reishi mushroom compliments coffee by being a good ally that positively influences better lung function.
Can Organo Gold ultimately play a major role in unlocking solutions for common diseases? Founder, Bernardo Chua is excited about the prospect of Organo Gold becoming more than just a healthy beverage. Established in 2008, in British Columbia, the company can be found in more than 50 countries today. The company has also won numerous awards, including People’s Choice and the Gold Medal from Napolean Hill Foundation. Visit crunchbase.com to know more about Organo Gold.
Dr. Clay Siegall is an expert in the medical field; he is also the founder and the Chief Executive Officer of Seattle Genetics which is a pharmaceutical firm which since it was created it has been concentering on the development of drugs used in diseases which are considered to be lack humanity enhancement for an extended period. Together with his partner, Dr. Clay co-founded Seattle Genetics in 1998; Clay has been at the forefront of leading the biotech organization and has helped in the success as well as the expansion of the group. Through Dr. Siegall’s experience, the firm developed their first FDA approved antibody drug conjugate. Their first drug has evolved and now has several other drugs, and more than 20 drugs are in the channel of development.
Dr. Clay Siegall went through High School, and after his graduation, he pursued his studies at the University of Maryland where he graduated with a Bachelors of Science in Zoology, and alter he attained his Ph.D.in genetics from George Washington University. Seattle has also had partnership with other pharmaceutical firms including; Genentech, Pfizer, as well as Bayer among others. Through Clay’s leadership and insight, the pharmaceutical company has grown from a small start-up to become a giant in the pharmaceutical as well as the medical industry.
Dr. Clay Siegall is the Co-founder and the Chief Executive Officer of Settle Genetics which is a leader in the manufacturing and development of drugs. Before co-founding Seattle, Clay served at Bristol- Meyer Squibb Pharmaceutical Research Institute, National Institute of Health, as well as National Cancer Institute. He is a leader who has shown positive leadership character as well as an incredible leadership that is why he has served on several Board of governors include; Ultragenyx Pharmaceuticals as the Board of Director, Washington Roundtable, and Alder BioPharmaceuticals. Having an experience which runs for many years; the doctor who has a passion for cancer patients, as well as the treatment, has been recognized on various occasions. Some of the awards which he has received include; the Year of Computer at the University of Maryland among many others. He is not only a medical doctor, but he is also an author.
In February 2017, Cancer Treatment Centers of America partnered with NantHealth and Allscripts to establish new comprehensive treatment plans for more customized oncology treatment platforms called Clinical Pathways. In this context, comprehensive means that it includes the latest upgrades of therapies, cancer research and treatments. Clinical Pathways is designed to keep physicians apprised of the treatment process without the constant guesswork and interruption in the work flow. In other words, it basically works as its own ecosystem of the treatment plans.Clinical Pathways also allows for a more transparent of the care plan treatments.
It also allows for comparison shopping between options, maps of every treatment regiment currently recommended by eviti, order entries with just a tap of the screen, and the latest clinical data and present up-to-date guidelines of the general reactions to the treatments.Cancer Treatment Centers of America (CTCA) is currently a network of five hospitals that specialize in treating cancer patients. It was established in 1988 by Richard Stephenson whose mother succumbed to cancer and he wasn’t satisfied with the available treatment options of that time.
The first location to open was the one in Zion, Illinois and the other four followed between 2005 and 2012.CTCA combines traditional treatment, such as chemotherapy and radiation, with integral therapies to help patients cope with the physical side effects, pain, anxiety and depression issues. Aside from the five locations in the U.S., they also opened an information office in Mexico City in 2015. Their brand has become well-known in Latin America, Carribeans and the Middle East so it is also possible for cancer patients in those areas to receive treatment at one of the five locations in the U.S. Four of the five locations have received three-year accreditations for their breast programs.
Paul Mampilly is a prominent serial entrepreneur and investor based in the United States. In 2016, Paul Mampilly joined the Banyan Publishing Hill to serve as their senior editor. His work was specializing in assisting the Main Street Americans to find wealth in growth technology and investment opportunities. Paul Mampilly commenced his business career in 1991 working for the Wall Street Business Planning Entity. Moreover, Paul Mampilly worked as the Banker’s Trust portfolio manager during his preliminary years of experience as an investment advisor. Paul Mampilly also worked hard to advance in his profession when he became the investment advisor for the Deutsche Bank to manage multi-million dollar accounts on behalf of owners.
In 2006, the owners of the Kinetics Assets Company, worth more than $6 billion, recruited Paul Mampilly as the new asset and investment manager. Paul Mampilly has always worked to enrich his success in management investment. Perhaps this is why he is the most coveted investment advisor in the industry. When Paul Mampilly worked for the Kinetics Asset Management company fir five years, the value of assets under the company’s investment rose from $6 billion to $25 billion. This is one of his greatest achievements as an investment advisor.
Few people have accessed better business solutions through the knowledge they gain from their education. Paul Mampilly is one of the few who makes good use of the knowledge they scooped from the school of business from the Virginia-based Virginia State University. Under his rule in the Kinetics Asset Management Company, Paul Mampilly made it become one of the world-largest and most successful hedge fund companies. Paul Mampilly is one of the few people who can turn an investment of $50 million to $88 million a year. The most impressive part was that he achieved this action during the 2009 economic recession.
In the end, Paul Mampilly was tired working for the richest people in the world. Therefore, he decided to retire from active business investment for a better world tomorrow. Instead of making the rich people richer, he commenced an action to make the poor people richer. Paul Mampilly went on to found the Profits Unlimited Company that assists the young people to make sound investment plans for a brighter future. When Paul Mampilly wanted to get out of the Wall Street, he was determined to develop a new plan to assist him to succeed in enriching the people. This was when the idea of Profits Unlimited came into action.
Paul Mampilly’s Facebook Page: www.facebook.com/PaulMampillyGuru/
James Dondero currently serves at Highland Capital Management L.P as co-founder and president. He attended University of Virginia McIntire School of Commerce and graduated with a bachelor of commerce majoring in finance and accounting in 1984. Dondero has certification in both public accountancy and managerial accountancy that earned his designation as Chartered Finance Analyst. Visit his website at jamesdondero.com.
James Dondero career journey
Dondero is the current president at Highland Capital Management founded in 1993 and he has over 30 years of experience in the equity and credit market. Under his leadership, Highland Capital Management has been able to offer award-winning solutions and products from both the retail and institutional investors. The company has $13.5 billion estimated assets and has received numerous awards recently including, 2014 Lipper Award for Floating Rate Opportunities, 5-star designation from Morningstar for Global Allocation and it was ranked top in the Healthcare Short/ Long Equity Fund in 2014.
James Dondero also serves as the chairman of the Nexpoint, CCS Medical, Cornerstone Healthcare and NexBank boards. He is a board member at MGM Studios, American Banknote and Southern Methodist University Cox School of Business.
His career began at JP Morgan Training Program in 1984, where he served as an analyst. He joined American Express in 1985 as a corporate bond analyst and was promoted to portfolio manager; he left in 1989. He was part of the investors that created Protective Life subsidiary the GIC as the chief investment officer. While at GIC he helped it to get to over $2 billion from inception.
Dondero Philanthropic Activities
James Dondero has always been dedicated too philanthropic activities as he strives to make an impact in Dallas, as he is thrilled to work in a company that cares about providing rewarding experiences to the Dallas residents. He together with the Highland Capital Management funded the George W. Bush Presidential Library Institute and Perot Museum of Natural sciences.
Dondero also helps the Dallas Zoo. In solidarity with the president and CEO of the Dallas Foundation, Mary Jalonick, they formed the Highland Dallas Foundation Inc. that serves in the comprehensive way of selecting charitable activities for James. The foundation focuses on North Texas and supports, various civic organizations, educational needs, veterans and health care concerns. Read more about James Dondero on Bloomberg.com.
Jason Hope is an successful Businessman as well as Investor. Mr. Hope has always had an interest in scientific research projects that were related to anti-aging studies as well as improving ones health through lifestyle modifications and medications. In addition, Mr. Hope strongly supports the SENS Research Foundation.
The SENS Foundation supports anti-aging studies and research. The foundation normally conducts conferences to discuss a variety of topics related to aging research. In addition, the SENS foundation hopes to increase awareness about anti-aging research in hopes of raising additional monies to assist researchers with their very important studies. Researchers hope to develop new drugs that will help with age reversal.
Jason Hope has contributed large sums of money to assist SENS with their research projects. Jason Hope is a firm believer in the benefits that could result if the aging process could be reversed or even altered to slow the progression of old age. Seven Years ago Jason Donated six figures to SENS to assist in keeping their research project going. Due to Mr. Hope’s generosity SENS was able to build an additional research facility to conduct further research.
Jason Hope’s contributions also enabled researchers to conduct studies that enabled end products to be broken down into human tissue. This project is another step in the right direction that may help drug companies develop new anti-aging wonder type drugs. Research also involves attempting to find cures to diseases such as Alzheimer and other related diseases that cause the human body to break down physically and mentally.
It seems that traditional medicine simply can not solve problems involving old age. Therefore, a great deal more research as well as case studies are necessary before new facts and discoveries are revealed.
Finally, Jason Hope is a self made highly ambitious businessman that has certainly given back in an attempt to one day help others benefit from his generosity. In addition, Mr. hope is highly educated. He received a Degree in Business from Arizona State University. In addition, Hope returned to Arizona State to further his education with an MBA Degree. Mr. Hope acts as an adviser concerning a variety of business and investment matters. He also conducts public speaking engagements in his free time.
Learn More: inspirery.com/jason-hope/